Press Release Description

Global Minimally Invasive Surgical Systems market is expected to grow at a CAGR of 7.6% during 2021-26.

According to the MarkNtel Advisors' research report, "Global Minimally Invasive Surgical Systems Market Analysis, 2021," the market is likely to grow at a CAGR of 7.6% during 2021-26. Minimally invasive surgical systems are becoming standard for many traditional procedures done with open surgery owing to their benefits like smaller incisions, reduced pain, faster recovery times, and scarring, thereby fueling the market growth. Additionally, minimally invasive surgical procedures offer a higher accuracy rate compared to traditional open surgery. Further, the integration of robotic technology with minimally invasive surgical systems allows precise control over the surgery, thereby resulting in higher success rates which, in turn, is propelling the overall market growth.

Key questions answered in the study

1. What are the current and future trends in the Global Minimally Invasive Surgical Systems market? 
2. How has the industry been evolving in terms of geography and services adoption?
3. How has the competition been shaping across the countries, followed by their comparative factorial indexing?
4. What are the key growth drivers and challenges for the Global Minimally Invasive Surgical Systems market?
5. What are the customer orientation, purchase behavior, and expectations from the Global Minimally Invasive Surgical Systems market service providers across various regions? 

Cardiovascular Surgery Exhibits Fastest Growth

Based on the Application, the market bifurcates into Urology Surgery, Gynecology Surgery, General Surgery, Cardiovascular Surgery, Orthopedic Surgery, and Head & Neck Surgery (Neurosurgery). Among these, the Cardiovascular Surgery segment is likely to grow at a considerable rate due to the mounting geriatric populace and the increasing prevalence of cardiac diseases. Further, minimally invasive surgical procedures involve minimal blood loss, lower risk of infection, lesser noticeable scars, less pain & trauma, faster recovery, and shorter duration of hospitalization. Therefore, demand for minimally invasive surgical systems is significantly increasing for cardiovascular surgeries, thereby fueling the market growth. 

“Global Minimally Invasive Surgical Systems Market Analysis, 2021” provides comprehensive, qualitative, and quantitative insights on the market potential, key factors impacting the market growth, hotspots, and opportunities available for Minimally Invasive Surgical Systems providers across the globe. Moreover, the report also encompasses the key strategic imperatives for competitors' success and strategic factorial indexing to measure their capabilities on 16 parameters, which will help companies formulate 'Go to Market' strategies and identify the blue ocean for their offerings.   

Asia-Pacific Shows Substantial Growth

The Asia-pacific market is likely to register the fastest growth in the Global Minimally Invasive Surgical Systems market during 2021-26 due to the surging aging population in APAC countries like Japan and China. The developing economies of these countries promote the adoption of minimally invasive procedures in the entire region. 

Besides, growing medical tourism drives the demand for minimally invasive procedures in this region. Thereby, Asia Pacific is likely to contribute to the growth of the Global Minimally Invasive Surgical Systems Market in the forecast period, reveals MarkNtel Advisors research report, "Global Minimally Invasive Surgical Systems Market Analysis, 2021."

According to MarkNtel Advisors, the leading players in the Global Minimally Invasive Surgical Systems Market are Auris Health, Inc. (Johnson & Johnson), Boston Scientific Corporation, Cook Medical, Corindus Vascular Robotics Inc, Intuitive Surgical Inc, Medrobotics Corporation, Medtech SA (Zimmer Biomet Holdings, Inc.), Mazor Robotics Ltd, Olympus Corporation, Renishaw Plc, Restoration Robotics Inc, Smith & Nephew Plc, Stereotaxis Inc, Mako Surgical Corp (Stryker Corporation), Think Surgical Inc., TransEnterix, Inc., Richard Wolf GmbH, Pentax Medical (Hoya Corporation), Fujifilm Holdings Corporation, and Siemens Healthcare GmbH.

Market Segmentation:

1. By Type (Conventional MISS [Endoscopes and Endoscopic Systems (Rigid Endoscopes {Laparoscopes, Arthroscopes, Urology Endoscopes (Cystoscopes, Resectoscopes, Nephroscopes, Other Urology Endoscopes), Gynecology Endoscopes, Neuroendoscopes, ENT Endoscopes, Other Rigid Endoscopes (GI)}, Flexible Endoscopes {Gastrointestinal Endoscopes (Gastroscopes, Duodenoscopes, Enteroscopes, Sigmoidoscopes, Colonoscopes, Other GI Endoscopes), Urology Endoscopes, Gynecology Endoscopes, Bronchoscopes, Laryngoscopes, Pharyngoscopes, ENT Endoscopes}, Capsule Endoscopy {Workstations and Data Recorders, Capsules, Others (Services and Patency System)}), Video and Visualization Systems (Cameras {Single-Chip Cameras, 3-Chip Cameras}, Displays and Monitors {Wireless, Wired}, Video Convertors, Video Recorders {Standalone, Inbuilt}, Video Processors, Camera Heads {CCD, CMOS}, Light Sources {LED, XEON, Laser, Halogen} , Printers), Instruments and Accessories (Insufflators, Endoscope Tip Protector, Tubing, Water Systems, Procedure Kits, Forceps, Retrieval Kits, Injection Needles, Energy Devices, Closure Devices, Hand Instruments, Access Devices, Others), Others], Surgical Robotics [Systems, Instruments & Accessories, Services])
2. By Application (Urology Surgery, Gynecology Surgery, General Surgery, Cardiovascular Surgery, Orthopedic Surgery, Head and Neck Surgery (Neurosurgery), Others (Biopsy, Hair, etc.))
3. By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics)
4. By Region (North America, Latin America, Europe, Asia-Pacific, Middle East & Africa)
5. By Country (U.S, Canada, Brazil, Argentina, Mexico, Germany, France, The U.K, Russia, Spain, Italy, China, India, Japan, UAE, Saudi Arabia, Israel)
6. By Competitors (Auris Health, Inc. (Johnson & Johnson), Boston Scientific Corporation, Cook Medical, Corindus Vascular Robotics Inc, Intuitive Surgical Inc, Medrobotics Corporation, Medtech SA (Zimmer Biomet Holdings, Inc.), Mazor Robotics Ltd, Olympus Corporation, Renishaw Plc, Restoration Robotics Inc, Smith & Nephew Plc, Stereotaxis Inc, Mako Surgical Corp (Stryker Corporation), Think Surgical Inc., TransEnterix, Inc., Richard Wolf GmbH, Pentax Medical (Hoya Corporation), Fujifilm Holdings Corporation, Siemens Healthcare GmbH)